Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Infect Immun ; 72(3): 1423-30, 2004 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-14977947

RESUMO

Bacterial surface carbohydrates are important pathogenic factors in gram-negative pneumonia infections. Among these factors, O antigen has been reported to protect pathogens against complement-mediated killing. To examine further the role of O antigen, we insertionally inactivated the gene encoding a galactosyltransferase necessary for serotype O1 O-antigen synthesis (wbbO) from Klebsiella pneumoniae 43816. Analysis of the mutant lipopolysaccharide by sodium dodecyl sulfate-polyacrylamide gel electrophoresis confirmed the absence of O antigen. In vitro, there were no detectable differences between wild-type K. pneumoniae and the O-antigen-deficient mutant in regard to avid binding by murine complement C3 or resistance to serum- or whole-blood-mediated killing. Nevertheless, the 72-h 50% lethal dose of the wild-type strain was 30-fold greater than that of the mutant (2 x 10(3) versus 6 x 10(4) CFU) after intratracheal injection in ICR strain mice. Despite being less lethal, the mutant organism exhibited comparable intrapulmonary proliferation at 24 h compared to the level of the wild type. Whole-lung chemokine expression (CCL3 and CXCL2) and bronchoalveolar inflammatory cell content were also similar between the two infections. However, whereas the wild-type organism produced bacteremia within 24 h of infection in every instance, bacteremia was not seen in mutant-infected mice. These results suggest that during murine pneumonia caused by K. pneumoniae, O antigen contributes to lethality by increasing the propensity for bacteremia and not by significantly changing the early course of intrapulmonary infection.


Assuntos
Bacteriemia/etiologia , Infecções por Klebsiella/etiologia , Klebsiella pneumoniae/imunologia , Klebsiella pneumoniae/patogenicidade , Antígenos O/fisiologia , Pneumonia Bacteriana/etiologia , Animais , Sequência de Bases , Atividade Bactericida do Sangue , Líquido da Lavagem Broncoalveolar/citologia , Líquido da Lavagem Broncoalveolar/imunologia , Complemento C3/deficiência , Complemento C3/genética , Complemento C3/metabolismo , Citocinas/metabolismo , DNA Bacteriano/genética , Feminino , Genes Bacterianos , Klebsiella pneumoniae/genética , Pulmão/imunologia , Pulmão/microbiologia , Camundongos , Camundongos Endogâmicos ICR , Mutação , Antígenos O/genética , Fenótipo , Virulência
2.
Am J Respir Cell Mol Biol ; 29(4): 432-8, 2003 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-14500254

RESUMO

Complement is necessary for defense against lung infection with Pseudomonas aeruginosa in mice. We studied in vitro interactions between complement and P. aeruginosa and in vivo effects of complement depletion to better understand this relationship. In vitro, P. aeruginosa strain UI-18 was resistant to killing by mouse serum. However, C3 opsonized the organism (via the alternative and mannose binding lectin [MBL] pathways), and C5 convertase activity on the bacterial surface was demonstrated. In vivo, compared with normal mice, complement-deficient mice experienced higher mortality and failed to sterilize their bronchoalveolar space within 24 h of inoculation. These changes did not seem to be a result of decreased inflammation because complement-deficient mice had normal neutrophil recruitment, greater lung myeloperoxidase content, and, by 24 h, a 35-fold higher level of the CXC chemokine KC. Lung static pressure-volume curves were abnormal in infected animals but were significantly more so in complement deficient mice. These data indicate that although P. aeruginosa is resistant to serum killing, C3 opsonization and C5 convertase assembly occur on its surface. This interaction in vivo plays a central role in host survival beyond just recruitment and activation of phagocytes and may serve to limit the inflammatory response to and tissue injury resulting from bacterial infection.


Assuntos
Quimiocinas CXC , Proteínas do Sistema Complemento/deficiência , Pneumonia Bacteriana/imunologia , Infecções por Pseudomonas/imunologia , Pseudomonas aeruginosa/imunologia , Animais , Quimiocina CXCL1 , Quimiocinas/imunologia , Fatores Quimiotáticos/imunologia , Quimiotaxia de Leucócito/imunologia , Complemento C3/imunologia , Complemento C3/metabolismo , Convertases de Complemento C3-C5/imunologia , Convertases de Complemento C3-C5/metabolismo , Modelos Animais de Doenças , Feminino , Interações Hospedeiro-Parasita/imunologia , Peptídeos e Proteínas de Sinalização Intercelular/imunologia , Camundongos , Camundongos Endogâmicos C57BL , Camundongos Knockout , Mortalidade , Peroxidase/imunologia , Pneumonia/imunologia , Pneumonia/metabolismo , Pneumonia Bacteriana/fisiopatologia , Infecções por Pseudomonas/fisiopatologia , Alvéolos Pulmonares/imunologia , Alvéolos Pulmonares/microbiologia , Fenômenos Fisiológicos Respiratórios
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA